NEW YORK, Sept. 27 - A wholly owned subsidiary of Deltagen will create a new research and development center in Strasbourg, France, in a move designed to strengthen the company’s research presence on the continent, Deltagen said on Thursday. 

The unit, Deltagen Europe, said it chose the new location because of its proximity to the Institut de Genetique et de Biologie Moleculaire et Cellulaire, with which Deltagen has a “close research partnership.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.